Incyte to Buy Vega Therapeutics For Up to $2 Billion Incyte has agreed to buy Vega Therapeutics for up to $2 billion in a deal that expands the biopharmaceutical company’s hematology portfolio into bleeding disorders. Post navigation Previous Previous post: The 8 best credit cards for booking flightsNext Next post: What Is The 7/3 Split Rule In Trucking? Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News Johnson & Johnson to Buy Firefly Bio for $1 Billion 0 5 Features The iPad Pro Has That An iPad Air Doesn’t 0
